Company / Profit Margin
Sonoma Pharmaceuticals, Inc. Profit Margin History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-24.2%
FY2026
5-year range
-40.3% / -21.2%
FY2022-FY2026
Trend
+36.3%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has increased for 3 consecutive years, from -40.3% in FY2023 to -24.2% in FY2026.
Based on SEC 10-K filings.
-24.2% in FY2026 with a 5-year CAGR of -5.8%.
Improved from -38.8% to -24.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +16.1pp
- 5-Year Change
- -5.8pp
- 10-Year Change
- -
Key checks
Key Insights
- Sonoma Pharmaceuticals, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2026, profit margin increased 36.3% year-over-year.
- Peak profit margin was recorded in FY2018.
- Lowest profit margin in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | -24.2% | +36.3% |
| FY2025 | -38.0% | +2.2% |
| FY2024 | -38.8% | +3.6% |
| FY2023 | -40.3% | -90.0% |
| FY2022 | -21.2% | -14.9% |
| FY2021 | -18.4% | +70.3% |
| FY2020 | -62.2% | +27.7% |
| FY2019 | -86.0% | -218.9% |
| FY2018 | 72.3% | +166.7% |
| FY2017 | -108.5% | -83.2% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026